Why prevent, diagnose and treat congenital toxoplasmosis?
Open Access
- 1 March 2009
- journal article
- review article
- Published by FapUNIFESP (SciELO) in Memórias do Instituto Oswaldo Cruz
- Vol. 104 (2), 320-344
- https://doi.org/10.1590/s0074-02762009000200029
Abstract
Evidence that prevention, diagnosis and treatment of toxoplasmosis is beneficial developed as follows: antiparasitic agents abrogate Toxoplasma gondii tachyzoite growth, preventing destruction of infected, cultured, mammalian cells and cure active infections in experimental animals, including primates. They treat active infections in persons who are immune-compromised, limit destruction of retina by replicating parasites and thereby treat ocular toxoplasmosis and treat active infection in the fetus and infant. Outcomes of untreated congenital toxoplasmosis include adverse ocular and neurologic sequelae described in different countries and decades. Better outcomes are associated with treatment of infected infants throughout their first year of life. Shorter intervals between diagnosis and treatment in utero improve outcomes. A French approach for diagnosis and treatment of congenital toxoplasmosis in the fetus and infant can prevent toxoplasmosis and limit adverse sequelae. In addition, new data demonstrate that this French approach results in favorable outcomes with some early gestation infections. A standardized approach to diagnosis and treatment during gestation has not yet been applied generally in the USA. Nonetheless, a small, similar experience confirms that this French approach is feasible, safe, and results in favorable outcomes in the National Collaborative Chicago-based Congenital Toxoplasmosis Study cohort. Prompt diagnosis, prevention and treatment reduce adverse sequelae of congenital toxoplasmosis.Keywords
This publication has 166 references indexed in Scilit:
- Toxoplasmosis-Associated Neovascular Lesions Treated Successfully With Ranibizumab and Antiparasitic TherapyJAMA Ophthalmology, 2008
- Longitudinal Study of New Eye Lesions in Children with Toxoplasmosis Who Were Not Treated During the First Year of LifeAmerican Journal of Ophthalmology, 2008
- In Vitro Susceptibility of Various Genotypic Strains of Toxoplasma gondii to Pyrimethamine, Sulfadiazine, and AtovaquoneAntimicrobial Agents and Chemotherapy, 2008
- Toxoplasmic retinochoroiditis presenting in childhood: clinical findings in a UK surveyBritish Journal of Ophthalmology, 2006
- Newborn screening for congenital toxoplasmosis: feasible, but benefits are not establishedArchives of Disease in Childhood, 2006
- Globalization and the population structure of Toxoplasma gondiiProceedings of the National Academy of Sciences, 2006
- Fetal toxoplasmosis: Outcome of pregnancy and infant follow-up after in utero treatmentThe Journal of Pediatrics, 1989
- Intellectual deficits in children born withsubclinical congenital toxoplasmosis: A preliminary reportThe Journal of Pediatrics, 1973
- Subclinical central nervous system disease of neonates: A prospective study of infants born with increased levels of IgMThe Journal of Pediatrics, 1969
- Chorioretinopathy associated with other evidence ofcerebral damage in childhoodThe Journal of Pediatrics, 1949